These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 30487243)

  • 1. Targeted Therapy for EBV-Associated B-cell Neoplasms.
    Ganguly S; Kuravi S; Alleboina S; Mudduluru G; Jensen RA; McGuirk JP; Balusu R
    Mol Cancer Res; 2019 Apr; 17(4):839-844. PubMed ID: 30487243
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The combination of MLN2238 (ixazomib) with interferon-alpha results in enhanced cell death in melanoma.
    Suarez-Kelly LP; Kemper GM; Duggan MC; Stiff A; Noel TC; Markowitz J; Luedke EA; Yildiz VO; Yu L; Jaime-Ramirez AC; Karpa V; Zhang X; Carson WE
    Oncotarget; 2016 Dec; 7(49):81172-81186. PubMed ID: 27783987
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proteasomal Inhibition by Ixazomib Induces CHK1 and MYC-Dependent Cell Death in T-cell and Hodgkin Lymphoma.
    Ravi D; Beheshti A; Abermil N; Passero F; Sharma J; Coyle M; Kritharis A; Kandela I; Hlatky L; Sitkovsky MV; Mazar A; Gartenhaus RB; Evens AM
    Cancer Res; 2016 Jun; 76(11):3319-31. PubMed ID: 26988986
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A single center phase II study of ixazomib in patients with relapsed or refractory cutaneous or peripheral T-cell lymphomas.
    Boonstra PS; Polk A; Brown N; Hristov AC; Bailey NG; Kaminski MS; Phillips T; Devata S; Mayer T; Wilcox RA
    Am J Hematol; 2017 Dec; 92(12):1287-1294. PubMed ID: 28842936
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A New Perspective for Osteosarcoma Therapy: Proteasome Inhibition by MLN9708/2238 Successfully Induces Apoptosis and Cell Cycle Arrest and Attenuates the Invasion Ability of Osteosarcoma Cells in Vitro.
    Liu R; Fu C; Sun J; Wang X; Geng S; Wang X; Zou J; Bi Z; Yang C
    Cell Physiol Biochem; 2017; 41(2):451-465. PubMed ID: 28214890
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The evaluation of the anti-cancer activity of ixazomib on Caco2 colon solid tumor cells, comparison with bortezomib.
    Engür S; Dikmen M
    Acta Clin Belg; 2017 Dec; 72(6):391-398. PubMed ID: 28327055
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Small molecule growth inhibitors of human oncogenic gammaherpesvirus infected B-cells.
    Dzeng RK; Jha HC; Lu J; Saha A; Banerjee S; Robertson ES
    Mol Oncol; 2015 Feb; 9(2):365-76. PubMed ID: 25306391
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Wogonin as a targeted therapeutic agent for EBV (+) lymphoma cells involved in LMP1/NF-κB/miR-155/PU.1 pathway.
    Wu X; Liu P; Zhang H; Li Y; Salmani JM; Wang F; Yang K; Fu R; Chen Z; Chen B
    BMC Cancer; 2017 Feb; 17(1):147. PubMed ID: 28222771
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cell cycle arrest induced by engagement of B7-H4 on Epstein-Barr virus-positive B-cell lymphoma cell lines.
    Park GB; Song H; Kim YS; Sung M; Ryu JW; Lee HK; Cho DH; Kim D; Lee WJ; Hur DY
    Immunology; 2009 Nov; 128(3):360-8. PubMed ID: 20067536
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antitumor effects of duvelisib on Epstein-Barr virus-associated lymphoma cells.
    Kawada JI; Ando S; Torii Y; Watanabe T; Sato Y; Ito Y; Kimura H
    Cancer Med; 2018 Apr; 7(4):1275-1284. PubMed ID: 29522278
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An HIV protease inhibitor, ritonavir targets the nuclear factor-kappaB and inhibits the tumor growth and infiltration of EBV-positive lymphoblastoid B cells.
    Dewan MZ; Tomita M; Katano H; Yamamoto N; Ahmed S; Yamamoto M; Sata T; Mori N; Yamamoto N
    Int J Cancer; 2009 Feb; 124(3):622-9. PubMed ID: 18973272
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of constitutive NF-kappa B activation in mantle cell lymphoma B cells leads to induction of cell cycle arrest and apoptosis.
    Pham LV; Tamayo AT; Yoshimura LC; Lo P; Ford RJ
    J Immunol; 2003 Jul; 171(1):88-95. PubMed ID: 12816986
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preclinical evaluation of antitumor activity of the proteasome inhibitor MLN2238 (ixazomib) in hepatocellular carcinoma cells.
    Augello G; Modica M; Azzolina A; Puleio R; Cassata G; Emma MR; Di Sano C; Cusimano A; Montalto G; Cervello M
    Cell Death Dis; 2018 Jan; 9(2):28. PubMed ID: 29348495
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bortezomib induces apoptosis of Epstein-Barr virus (EBV)-transformed B cells and prolongs survival of mice inoculated with EBV-transformed B cells.
    Zou P; Kawada J; Pesnicak L; Cohen JI
    J Virol; 2007 Sep; 81(18):10029-36. PubMed ID: 17626072
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A mechanistic insight into a proteasome-independent constitutive inhibitor kappaBalpha (IkappaBalpha) degradation and nuclear factor kappaB (NF-kappaB) activation pathway in WEHI-231 B-cells.
    Shumway SD; Miyamoto S
    Biochem J; 2004 May; 380(Pt 1):173-80. PubMed ID: 14763901
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Constitutive activation of distinct NF-κB signals in EBV-associated nasopharyngeal carcinoma.
    Chung GT; Lou WP; Chow C; To KF; Choy KW; Leung AW; Tong CY; Yuen JW; Ko CW; Yip TT; Busson P; Lo KW
    J Pathol; 2013 Nov; 231(3):311-22. PubMed ID: 23868181
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cell-cycle regulators, bcl-2 and NF-kappaB in Epstein-Barr virus-positive gastric carcinomas.
    Chang MS; Lee HS; Jung EJ; Kim CW; Lee BL; Kim WH
    Int J Oncol; 2005 Nov; 27(5):1265-72. PubMed ID: 16211221
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Curcumin improves the antitumor effect of X-ray irradiation by blocking the NF-κB pathway: an in-vitro study of lymphoma.
    Qiao Q; Jiang Y; Li G
    Anticancer Drugs; 2012 Jul; 23(6):597-605. PubMed ID: 22273827
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The proteasome inhibitor bortezomib acts independently of p53 and induces cell death via apoptosis and mitotic catastrophe in B-cell lymphoma cell lines.
    Strauss SJ; Higginbottom K; Jüliger S; Maharaj L; Allen P; Schenkein D; Lister TA; Joel SP
    Cancer Res; 2007 Mar; 67(6):2783-90. PubMed ID: 17363600
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of di-allyl disulfide, a garlic component in NF-κB mediated transient G2-M phase arrest and apoptosis in human leukemic cell-lines.
    Dasgupta P; Bandyopadhyay SS
    Nutr Cancer; 2013; 65(4):611-22. PubMed ID: 23659453
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.